DNA-testing company 23andMe said on Monday that it was firing roughly 40% of its workforce, more than 200 people, as Chief ...

Genetic-testing lab 23andMe plans to cut its workforce by 40% and end its therapeutics program in an effort to cut costs, the ...

The therapeutic programs of 23andMe include an antibody that restores the ability of the immune system to kill cancer cells.

We remain deeply grateful to the patients, investigators and study staff for their participation in our clinical trials,” ...

DNA-testing company 23andMe Holding Co. will slash its workforce by about 40% and discontinue its therapeutics program as ...

"We are taking these difficult but necessary actions as we restructure 23andMe and focus on the long-term success of our core ...

The struggling genetic testing company 23andMe says it will cut 40% of its workforce, or 200 jobs, as it fights for survival.

Genetic testing firm 23andMe said on Monday it is reducing about 40 per cent, or 200 employees, from its workforce and ...

Me's big push into drug development, announced with great fanfare almost a decade ago, has ended with a whimper and sweeping ...

However, 23andMe expects that these measures will eventually save them as much as $35 million. The company's CEO, Anne ...

Reduces workforce by roughly 40%; expects annualized cost savings of more than $35 million Discontinues development of therapeutics division and commences strategic alternatives process for all ...